27. Mai 2018 | Verschiedenes
A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder.
A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder.
El Hage C, Ghabrash MF, Dubreucq S, Brissette S, Lespérance F, Lespérance P, O…